By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Rexahn Pharmaceuticals, Inc. 

15245 Shady Grove Road
Suite 455
Rockville  Maryland  20850  U.S.A.
Phone: 240-268-5300 Fax: 240-268-5310


Company News
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Appointment Of Peter Brandt As Chairman Of The Board 6/22/2015 11:46:10 AM
National Cancer Institute Accepts Rexahn Pharmaceuticals, Inc. (RNN)'s RX-21101 For Its Nanotechnology Characterization Laboratory's Preclinical Characterization Program 6/8/2015 7:50:46 AM
Rexahn Pharmaceuticals, Inc. (RNN) Announces Poster Presentations At The 2015 ASCO Annual Meeting 5/14/2015 12:55:27 PM
Rexahn Pharmaceuticals, Inc. (RNN) Reports First Quarter 2015 Financial Results And Pipeline Update 5/11/2015 8:38:06 AM
New Data Show Rexahn Pharmaceuticals, Inc. (RNN)'s Supinoxin Decreases The Migration Of Human Triple Negative Breast Cancer Cells In A Metastatic Cancer Model 4/21/2015 8:02:49 AM
Rexahn Pharmaceuticals, Inc. (RNN) Identifies RX-3117 Biomarker & Presents Data At The 2015 AACR Annual Meeting 4/20/2015 8:39:59 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present Data On RX-3117 And Supinoxin At The 2015 American Association for Cancer Research Annual Meeting 4/13/2015 7:57:36 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The 12th Annual BIO Asia International Conference In Tokyo, Japan 3/18/2015 7:50:09 AM
Rexahn Pharmaceuticals, Inc. (RNN) Reports Fourth Quarter And Full-Year 2014 Financial Results And Pipeline Update 3/17/2015 7:42:41 AM
Rexahn Pharmaceuticals, Inc. (RNN) To Present At The BIO-Europe Spring 2015 Conference In Paris, France 3/4/2015 8:47:34 AM